Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jan. 31, 2024	Jul. 31, 2023
Current assets
Cash	$ 75	$ 7
Prepaid expenses	26	16
Total current assets	101	23
Total assets	101	23
Current liabilities
Accounts payable and accrued expenses	233	240
Current liabilities – discontinued operations	51	51
Total current liabilities	284	291
Total liabilities	855	635
Commitments and contingencies (Note 7)
Shareholders’ deficit
Series B Preferred Stock, par value $1.00 per share; 100 shares authorized, issued and outstanding; liquidation preference $10
Common Stock, par value $0.01 per share; 400,000,000 shares authorized; 154,810,655 shares issued and outstanding as of January 31, 2024 and July 31, 2023	1,548	1,548
Additional paid in capital	26,574	26,574
Accumulated deficit	(28,876)	(28,734)
Total shareholders’ deficit	(754)	(612)
Total liabilities and shareholders’ deficit	101	23
Related Party [Member]
Current liabilities
Notes payable – related parties	500	300
Accrued interest – related parties	$ 71	$ 44